Skip to main content

Advertisement

Log in

Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Cigarette smoking is thought to increase the risk of Crohn’s disease (CD) and exacerbate the disease course, with opposite roles in ulcerative colitis (UC). However, these findings are from Western populations, and the association between smoking and inflammatory bowel disease (IBD) has not been well studied in Asia.

Aims

We aimed to compare the prevalence of smoking at diagnosis between IBD cases and controls recruited in China, India, and the USA, and to investigate the impact of smoking on disease outcomes.

Methods

We recruited IBD cases and controls between 2014 and 2018. All participants completed a questionnaire about demographic characteristics, environmental risk factors and IBD history.

Results

We recruited 337 participants from China, 194 from India, and 645 from the USA. In China, CD cases were less likely than controls to be current smokers (adjusted odds ratio [95% CI] 0.4 [0.2–0.9]). There was no association between current or former smoking and CD in the USA. In China and the USA, UC cases were more likely to be former smokers than controls (China 14.6 [3.3–64.8]; USA 1.8 [1.0–3.3]). In India, both CD and UC had similar current smoking status to controls at diagnosis. Current smoking at diagnosis was significantly associated with greater use of immunosuppressants (4.4 [1.1–18.1]) in CD cases in China.

Conclusions

We found heterogeneity in the associations of smoking and IBD risk and outcomes between China, India, and the USA. Further study with more adequate sample size and more uniform definition of smoking status is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med. 2009;361:2066–2078.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology. 2011;140:1785–1794.

    Article  PubMed  Google Scholar 

  3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54.e42; quiz e30.

    Article  PubMed  Google Scholar 

  4. Fung WP, Monteiro EH, Murugasu JJ, Ng KC, Kho KM, Lee SK. Non-specific ulcerative colitis in Chinese and Indians in Singapore. Med J Aust. 1971;2:361–365.

    CAS  PubMed  Google Scholar 

  5. Lee SK. Crohn’s disease in Singapore. Med J Aust. 1974;1:266–269.

    CAS  PubMed  Google Scholar 

  6. Leong RW, Lau JY, Sung JJ. The epidemiology and phenotype of Crohn’s disease in the Chinese population. Inflamm Bowel Dis. 2004;10:646–651.

    Article  PubMed  Google Scholar 

  7. Morita N, Toki S, Hirohashi T, et al. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol. 1995;30:1–4.

    Article  PubMed  Google Scholar 

  8. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008;14:542–549.

    Article  PubMed  Google Scholar 

  9. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.

    Article  CAS  PubMed  Google Scholar 

  10. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.

    Article  CAS  PubMed  Google Scholar 

  11. Brant SR, Wang MH, Rawsthorne P, et al. A population-based case-control study of CARD15 and other risk factors in Crohn’s disease and ulcerative colitis. Am J Gastroenterol. 2007;102:313–323.

    Article  CAS  PubMed  Google Scholar 

  12. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015;47:979–986.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Roth MP, Petersen GM, McElree C, Vadheim CM, Panish JF, Rotter JI. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews. Gastroenterology. 1989;96:1016–1020.

    Article  CAS  PubMed  Google Scholar 

  14. Weterman IT, Pena AS. Familial incidence of Crohn’s disease in The Netherlands and a review of the literature. Gastroenterology. 1984;86:449–452.

    CAS  PubMed  Google Scholar 

  15. Wang PQ, Hu J, Al Kazzi ES, et al. Family history and disease outcomes in patients with Crohn’s disease: a comparison between China and the United States. World J Gastrointest Pharmacol Ther. 2016;7:556–563.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Wang XQ, Zhang Y, Xu CD, et al. Inflammatory bowel disease in Chinese children: a multicenter analysis over a decade from Shanghai. Inflamm Bowel Dis. 2013;19:423–428.

    Article  PubMed  Google Scholar 

  17. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013;145:158–165.e152.

    Article  PubMed  Google Scholar 

  18. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205–217.

    Article  PubMed  Google Scholar 

  19. Mayberry J. A review of environmental factors and Crohn’s disease. Tijdschrift voor gastro-enterologie. 1978;21:267–271.

    CAS  PubMed  Google Scholar 

  20. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. Br Med J (Clinical research ed.). 1982;284:706.

    Article  CAS  Google Scholar 

  21. National Center for Chronic Disease P, Health Promotion Office on S, Health. Reports of the Surgeon General. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): Centers for Disease Control and Prevention (US); 2014.

  22. Harris PA, Scott KW, Lebo L, Hassan N, Lightner C, Pulley J. ResearchMatch: a national registry to recruit volunteers for clinical research. Acad Med. 2012;87:66–73.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.

    Article  PubMed  Google Scholar 

  24. Ng SC, Tang W, Leong RW, et al. Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific. Gut. 2015;64:1063–1071.

    Article  PubMed  Google Scholar 

  25. Niu J, Miao J, Tang Y, et al. Identification of environmental factors associated with inflammatory bowel disease in a southwestern highland region of China: a nested case-control study. PLoS ONE. 2016;11:e0153524.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Moon CM, Park DI, Kim ER, et al. Clinical features and predictors of clinical outcomes in Korean patients with Crohn’s disease: a Korean association for the study of intestinal diseases multicenter study. J Gastroenterol Hepatol. 2014;29:74–82.

    Article  PubMed  Google Scholar 

  27. Reif S, Lavy A, Keter D, et al. Lack of association between smoking and Crohn’s disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol. 2000;95:474–478.

    Article  CAS  PubMed  Google Scholar 

  28. Reif S, Klein I, Arber N, Gilat T. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology. 1995;108:1683–1687.

    Article  CAS  PubMed  Google Scholar 

  29. Eliakim R, Reif S, Lavy A, et al. Passive smoking in patients with inflammatory bowel disease: an Israeli multicentre case-control study. Eur J Gastroenterol Hepatol. 2000;12:975–979.

    Article  CAS  PubMed  Google Scholar 

  30. Ng SC, Zeng Z, Niewiadomski O, et al. Early course of inflammatory bowel disease in a population-based inception cohort study from 8 countries in Asia and Australia. Gastroenterology. 2016;150:86–95.e83; quiz e13-84.

    Article  PubMed  Google Scholar 

  31. Arora U, Ananthakrishnan AN, Kedia S, et al. Effect of oral tobacco use and smoking on outcomes of Crohn’s disease in India. J Gastroenterol Hepatol. 2018;33:134–140.

    Article  CAS  PubMed  Google Scholar 

  32. Sato Y, Matsui T, Yano Y, et al. Long-term course of Crohn’s disease in Japan: incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery. J Gastroenterol Hepatol. 2015;30:1713–1719.

    Article  PubMed  Google Scholar 

  33. Kuenzig ME, Lee SM, Eksteen B, et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016;16:143.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Sandler RS, Wurzelmann JI, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology (Cambridge, Mass.). 1992;3:374–378.

    Article  CAS  Google Scholar 

  35. Andersen V, Christensen J, Ernst A, et al. Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease. World J Gastroenterol. 2011;17:197–206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Nunes T, Etchevers MJ, Merino O, et al. Does smoking influence Crohn’s disease in the biologic era? The TABACROHN study. Inflamm Bowel Dis. 2013;19:23–29.

    Article  PubMed  Google Scholar 

  37. Aldhous MC, Drummond HE, Anderson N, Smith LA, Arnott ID, Satsangi J. Does cigarette smoking influence the phenotype of Crohn’s disease? Analysis using the Montreal classification. Am J Gastroenterol. 2007;102:577–588.

    Article  PubMed  Google Scholar 

  38. Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn’s disease. Gastroenterology. 1996;110:424–431.

    Article  CAS  PubMed  Google Scholar 

  39. Domenech E, Carrion S, Garcia-Planella E, et al. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:971–975.

    Article  PubMed  Google Scholar 

  40. Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn’s disease as defined by clinical variables. Dig Dis Sci. 2007;52:2897–2903.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We acknowledge ResearchMatch.org. Part of the recruitment for the study included was done via ResearchMatch, a national health volunteer registry that was created by several academic institutions and supported by the United States National Institutes of Health as part of the Clinical Translational Science Award (CTSA) program. ResearchMatch has a large population of volunteers who have consented to be contacted by researchers about health studies for which they may be eligible. We also acknowledge Girish Ganesh and Kavitha Medaboina for their help in recruiting participants at Asian Institute of Gastroenterology in Hyderabad, India. We acknowledge the grant support from Sun Yat-sen University Clinical Research 5010 Program (2014008), Ludwig-Bayless Science Award, and the Johns Hopkins Institute for Clinical and Translational Research (ICTR) which is funded in part by Grant Number UL1 TR 001079 from the National Center for Advancing Translational Sciences (NCATS) a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The contents are solely the responsibility of the authors and do not necessarily represent the official view of the Johns Hopkins ICTR, NCATS, or NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susan M. Hutfless.

Ethics declarations

Conflict of interest

No authors have conflict of interest with relation to this study.

Appendix

Appendix

See Tables 2, 3.

Table 2 The prevalence of ever exposure to passive smoking and its association with Crohn’s disease and ulcerative colitis
Table 3 The distribution of cumulative packs of cigarettes smoked at diagnosis and its association with Crohn’s disease and ulcerative colitis by country of recruitment

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, P., Hu, J., Ghadermarzi, S. et al. Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA. Dig Dis Sci 63, 2703–2713 (2018). https://doi.org/10.1007/s10620-018-5142-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-018-5142-0

Keywords

Navigation